期刊文献+

结直肠癌术前血清CEA、CA199表达水平与临床病理关系的研究 被引量:11

Study on the Relationship of Preoperative CEA and CA199 Serum Levels with Clinicopathology of Colorectal Cancer
下载PDF
导出
摘要 目的探讨术前血清中癌胚抗原(CEA)与糖类抗原199(CA199)水平与结直肠癌分期、分化程度、病理类型和细胞增殖(Ki-67)的关系。方法收集292例结直肠癌患者,检测其术前血清CEA和CA199水平,分析其表达水平在不同肿瘤TNM分期、分化程度、病理类型和细胞增殖(Ki-67)的差异。结果血清CEA水平升高与肿瘤TNM分期、分化程度、病理类型存在明显统计学差异,血清CA199水平升高与肿瘤TNM分期、分化程度存在明显统计学差异,肿瘤TNM分期越晚,血清CA199水平越高(P<0.05)。血清CEA、CA199升高与Ki67无明显统计学差异。结论结直肠癌患者术前血清CEA和CA199水平可作为评估结直肠癌临床病理关系的指标之一。 Objective To investigate the relationship of serum CEA,CA199 concentration with TNM staging,differentiation grade, pathology type and cell proliferation of coloreetal cancer. Methods There were total 292 cases collected. The differences of the serum concentration of CEA and CA199 were analyzed by stastics among clinicopathology parameters. Results The high level serum CEA were statistically significant between TNM staging,differentiation grade,pathology type(P 〈 0.05 ). The high level serum CA199 were statisti- cally significant between TNM staging, differentiation grade (P 〈 0.05 ). The advancer of the TNM staging was, the higher concentration of serum CA 199 was (P 〈 0.05). Conclusion Preoperative serum concentration of CEA and CA199 could be one of the indicators to assess the elinicopathology of coloreetal cancer.
出处 《医学研究杂志》 2012年第3期27-30,共4页 Journal of Medical Research
基金 2010年上海市卫生局科研计划资助项目(2009113) 上海市重点学科建设资助项目(B905)
关键词 结直肠癌 CEA CA199 临床病理关系 Colorectal cancer CEA CA199 Clinicopathology relationship
  • 相关文献

参考文献2

二级参考文献16

  • 1陈虞梅,黄钢.肿瘤标志物CEA,CA50和CA19-9在大肠癌诊断中的意义[J].放射免疫学杂志,2005,18(1):8-10. 被引量:27
  • 2M. Galindo Gallego M.D.,M. J. Fernández Ace?ero M.D.,J. Sanz Ortega M.D.,A. Aljama Delgado,J. L. Balibrea Cantero M.D.Prognostic influence of p53 nuclear overexpression in colorectal carcinoma[J].Diseases of the Colon & Rectum.2000(7)
  • 3O. Dworak,L. Keilholz,A. Hoffmann.Pathological features of rectal cancer after preoperative radiochemotherapy[J].International Journal of Colorectal Disease.1997(1)
  • 4WongNA,Brett L,Stewart M,Leitch A,Longley DB,Dunlop MG,Johnston PG,Lessells AM,Jodrell DI.Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma[].Br J Cancer.2001
  • 5HeidelbergerC,Chaudhari N,Danenberg PV.Fluorinate pyrimidines: a new class of tumor-inhibitory compounds[].Nature.1957
  • 6PopatS,Matakidou A,Houlston RS.Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis[].J Clin Oncol.2004
  • 7JakobC,Aust DE,Meyer W,Baretton GB,Schwabe W,Hausler P,Becker H,Liersch T.Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU- based neo-adjuvant chemoradiotherapy in rectal cancer[].J Pathol.2004
  • 8JakobC,Liersch T,Meyer W,Baretton GB,Hausler P,Schwabe W,Becker H,Aust DE.Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant[].Am J Surg Pathol.2005
  • 9JakobC,Liersch T,Meyer W,Baretton GB,Schwabe W,Hausler P,Kulle B,Becker H,Aust DE.Prognostic value ofhistologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy[].Am J Surg Pathol.2006
  • 10AhnenDJ,Feigl P,Quan G,Fenoglio-Preiser C,Lovato LC,Bunn PA Jr,Stemmerman G,Wells JD,Macdonald JS,Meyskens FL Jr.Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study[].Cancer Res.1998

共引文献34

同被引文献88

引证文献11

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部